Skip to Content

Pharming Group PHGUF

Morningstar Rating
$1.17 −0.12 (9.30%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHGUF is trading at a 7% discount.
Price
$1.17
Fair Value
$3.85
Uncertainty
High
1-Star Price
$8.14
5-Star Price
$2.16
Economic Moat
Zdzq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHGUF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.29
Day Range
$1.171.17
52-Week Range
$0.961.59
Bid/Ask
$1.09 / $1.17
Market Cap
$771.24 Mil
Volume/Avg
2,192 / 36,140

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.65
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
332

Comparables

Valuation

Metric
PHGUF
NAMS
PHVS
Price/Earnings (Normalized)
Price/Book Value
3.674.356.18
Price/Sales
3.65139.50
Price/Cash Flow
Price/Earnings
PHGUF
NAMS
PHVS

Financial Strength

Metric
PHGUF
NAMS
PHVS
Quick Ratio
3.5010.159.85
Current Ratio
4.2910.1510.46
Interest Coverage
−2.48−2,390.51
Quick Ratio
PHGUF
NAMS
PHVS

Profitability

Metric
PHGUF
NAMS
PHVS
Return on Assets (Normalized)
−5.27%−28.72%−50.56%
Return on Equity (Normalized)
−10.89%−32.12%−56.14%
Return on Invested Capital (Normalized)
−3.22%−33.51%−56.14%
Return on Assets
PHGUF
NAMS
PHVS
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRFjw$541.7 Bil
VRTX
Vertex Pharmaceuticals IncFjrkcm$111.3 Bil
REGN
Regeneron Pharmaceuticals IncKgbfb$109.0 Bil
MRNA
Moderna IncFnkx$36.8 Bil
ARGX
argenx SE ADRHqs$24.3 Bil
BNTX
BioNTech SE ADRVjbn$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncCkzfnv$20.0 Bil
BMRN
Biomarin Pharmaceutical IncQrxxmz$17.1 Bil
RPRX
Royalty Pharma PLC Class AVnknl$14.0 Bil
INCY
Incyte CorpVmplrjf$13.7 Bil

Sponsor Center